ARCHIVES

Andrew von Eschenbach Sworn In As NCI Director.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004

NIH Advisors Suggest Revamping Grant Application Review

June 14, 1996

Trial Shows Standard-Dose Radiotherapy Safer, More Effective than Higher Doses

May 31, 2013

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

DCPC Concepts Approved For Tw Grants Support Contract

January 31, 1986

In Brief: Moffitt Cancer Center Awarded Core Grant; Biotech Industry Honors Jeffords, Bliley

May 29, 1998